Leap Therapeutics Inc (LPTX)

Leap Therapeutics Inc Azioni (LPTX) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	0.03% 14.82	14.82	14.83	14.66	42.73
Operating Income/Loss	0.03% -14.82	-14.82	-14.83	-14.66	-42.73
Income/Loss From Continuing Operations Before Tax	10.87% -13.82	-12.46	-13.70	-13.39	-41.86
Income/Loss From Continuing Operations After Tax	10.87% -13.82	-12.46	-13.70	-13.39	-41.86
Net Income/Loss	10.87% -13.82	-12.46	-13.70	-13.39	-41.86
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1,125% 27.01	2.2047	26.99	14.71	129.34
Diluted Average Shares	1,125% 27.01	2.2047	26.99	14.71	129.34
Basic Earnings Per Share	155.00% -0.51	-0.20	-0.51	-0.91	-0.32
Diluted Earnings Per Share	155.00% -0.51	-0.20	-0.51	-0.91	-0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-